DS SMITH PLC financials
DS SMITH PLC
Country: GB Reporting currency: GBP Latest annual report: 2024-04-30
LEI:
39RSBE4RCI4M15BLWH36 Financial statements
(GBP, as reported — unscaled; 105 line items across 2 annual periods)
| Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | £6.82B | £8.22B |
| Operating expenses | £6.12B | £7.36B |
| Employee benefits expense | £1.0M | £1.0M |
| Operating profit (EBIT) | £604.0M | £733.0M |
| Net finance income / (cost) | -£103.0M | -£74.0M |
| Finance costs | £116.0M | £75.0M |
| Profit before tax | £503.0M | £661.0M |
| Income tax expense | £118.0M | £169.0M |
| Profit for the year | £385.0M | £503.0M |
| — attributable to owners | £385.0M | £502.0M |
| — attributable to NCI | £0 | £1.0M |
| Total comprehensive income | £110.0M | £133.0M |
| Per share | ||
| Basic EPS | £0.28 | £0.37 |
| Diluted EPS | £0.28 | £0.36 |
| Free cash flow / share | £-0.16 | £0.23 |
| Cash flow statement | ||
| Cash generated from operations | £555.0M | £1.08B |
| Net cash from operating activities | £320.0M | £866.0M |
| Net cash from investing activities | -£614.0M | -£526.0M |
| Net cash from financing activities | £352.0M | -£728.0M |
| Dividends paid | £247.0M | £289.0M |
| Proceeds from borrowings | £1.28B | £332.0M |
| Repayments of borrowings | £616.0M | £679.0M |
| Lease liability payments | £72.0M | £106.0M |
| Net change in cash | £58.0M | -£388.0M |
| Balance sheet | ||
| Total assets | £9.25B | £9.46B |
| Non-current assets | £6.93B | £6.93B |
| Property, plant & equipment | £3.74B | £3.53B |
| Right-of-use assets | £237.0M | £224.0M |
| Intangible assets & goodwill | £2.81B | £2.93B |
| Current assets | £2.33B | £2.53B |
| Inventories | £591.0M | £619.0M |
| Trade & other receivables | £1.13B | £1.26B |
| Cash & equivalents | £499.0M | £472.0M |
| Total equity | £3.95B | £4.09B |
| — attributable to owners | £3.95B | £4.08B |
| Non-controlling interests | £0 | £3.0M |
| Non-current liabilities | £2.61B | £2.33B |
| Long-term borrowings | £2.04B | £1.74B |
| Lease liabilities (non-current) | £164.0M | £154.0M |
| Current liabilities | £2.70B | £3.04B |
| Short-term borrowings | £397.0M | £74.0M |
| Lease liabilities (current) | £75.0M | £70.0M |
| Trade & other payables | £1.82B | £2.25B |
| Deferred tax liabilities | £213.0M | £262.0M |
| Derived metrics | ||
| Free cash flow | -£227.0M | £321.0M |
| Operating margin | 8.9% | 8.9% |
| Net margin | 5.6% | 6.1% |
| Return on equity | 9.7% | 12.3% |
| Cash conversion ratio | 0.83× | 1.72× |
| Capex coverage | 0.58× | 1.59× |
| Other reported items | ||
| Bank Overdrafts Classified As Cash Equivalents | £89.0M | £104.0M |
| Basic Earnings Loss Per Share From Continuing Operations | £0.28 | £0.36 |
| Cash and Cash Equivalents If Different From Statement of Financial Position | £410.0M | £368.0M |
| Cash Flows From Losing Control of Subsidiaries Or Other Businesses Classified As Investing Activities | £5.0M | £0 |
| Cash Flows From Used In Decrease Increase In Restricted Cash and Cash Equivalents | £0 | -£2.0M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | £113.0M | £0 |
| Comprehensive Income Attributable To Noncontrolling Interests | £0 | £1.0M |
| Comprehensive Income Attributable To Owners of Parent | £110.0M | £132.0M |
| Current Biological Assets | £5.0M | £6.0M |
| Current Derivative Financial Assets | £64.0M | £154.0M |
| Current Derivative Financial Liabilities | £122.0M | £319.0M |
| Current Provisions | £60.0M | £54.0M |
| Current Tax Assets | £37.0M | £24.0M |
| Current Tax Liabilities | £134.0M | £165.0M |
| Deferred Tax Assets | £23.0M | £11.0M |
| Diluted Earnings Loss Per Share From Continuing Operations | £0.28 | £0.35 |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners | £82.0M | — |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | £0.06 | — |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -£16.0M | £10.0M |
| Finance Income | £14.0M | £2.0M |
| Income Tax Relating To Components of Other Comprehensive Income | -£44.0M | -£147.0M |
| Income Tax Relating To Components of Other Comprehensive Income That Will Be Reclassified To Profit Or Loss | -£43.0M | -£149.0M |
| Income Tax Relating To Components of Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss | -£1.0M | £2.0M |
| Income Taxes Paid Refund Classified As Operating Activities | £169.0M | £136.0M |
| Increase Decrease Through Sharebased Payment Transactions | -£4.0M | £13.0M |
| Increase Decrease Through Transfers and Other Changes Equity | -£248.0M | -£280.0M |
| Interest Paid Classified As Operating Activities | £80.0M | £78.0M |
| Interest Received Classified As Operating Activities | £14.0M | £2.0M |
| Investment Accounted For Using Equity Method | £17.0M | £17.0M |
| Issue of Equity | £7.0M | £4.0M |
| Issued Capital | £138.0M | £138.0M |
| Liabilities | £5.30B | £5.37B |
| Net Assets Liabilities | £3.95B | £4.09B |
| Noncurrent Biological Assets | £11.0M | £11.0M |
| Noncurrent Derivative Financial Assets | £15.0M | £165.0M |
| Noncurrent Derivative Financial Liabilities | £71.0M | £49.0M |
| Noncurrent Provisions | £8.0M | £11.0M |
| Other Comprehensive Income | -£275.0M | -£370.0M |
| Other Comprehensive Income Before Tax Cash Flow Hedges | -£236.0M | -£72.0M |
| Other Comprehensive Income Before Tax Exchange Differences On Translation | -£147.0M | £194.0M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | -£2.0M | £11.0M |
| Other Comprehensive Income Before Tax Hedges of Net Investments In Foreign Operations | £41.0M | -£74.0M |
| Other Inflows Outflows of Cash Classified As Financing Activities | -£2.0M | -£4.0M |
| Other Inflows Outflows of Cash Classified As Investing Activities | £0 | £2.0M |
| Other Noncurrent Payables | £31.0M | £34.0M |
| Other Noncurrent Receivables | £4.0M | £1.0M |
| Proceeds From Disposals of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets | £41.0M | £19.0M |
| Proceeds From Issuing Shares | £7.0M | £4.0M |
| Profit Loss From Continuing Operations | £385.0M | £492.0M |
| Profit Loss From Discontinued Operations | £0 | £11.0M |
| Purchase of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets | £547.0M | £545.0M |
| Reclassification Adjustments On Cash Flow Hedges Before Tax | -£25.0M | £573.0M |
| Reclassification Adjustments On Exchange Differences On Translation Before Tax | £0 | £3.0M |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | £2.0M | £2.0M |
| Share Premium | £2.26B | £2.25B |
Methodology
Every line item above is a fact tagged in DS SMITH PLC's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (GBP), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.